Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Drug delivery

Tracing the fate of AAV vectors in the body

Nature Biotechnology (2023)Cite this article

Subjects

A study of AAV gene therapy in monkeys proposes that integrated vectors may drive long-term transgene expression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Analysis of AAV genomes and transgene expression in the non-human primate liver.

References

  1. Greig, J. A. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01974-7 (2023).

    Article  PubMed  Google Scholar 

  2. Nathwani, A. C. et al. Blood 132 (Suppl. 1), 491 (2018).

  3. Pasi, K. J. et al. N. Engl. J. Med. 382, 29–40 (2020).

    Article  CAS  PubMed  Google Scholar 

  4. George, L. A. et al. N. Engl. J. Med. 385, 1961–1973 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Muhuri, M., Levy, D. I., Schulz, M., McCarty, D. & Gao, G. Mol. Ther. 30, 1364–1380 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nakai, H. et al. J. Virol. 75, 6969–6976 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sun, X. et al. Hum. Gene Ther. 21, 750–761 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fong, S. et al. Nat. Med. 28, 789–797 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sabatino, D. E. et al. Mol. Ther. 30, 2646–2663 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dalwadi, D. A. et al. Mol. Ther. 29, 2898–2909 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Grousbeck Gene Therapy Center, Schepens Eye Research Institute, Mass Eye and Ear, Boston, MA, USA

    Nerea Zabaleta

  2. Noscendo GmbH, Duisburg, Germany

    Irene Gil-Farina

Authors
  1. Nerea Zabaleta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irene Gil-Farina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irene Gil-Farina.

Ethics declarations

Competing interests

N.Z. declares no competing interests. I.G.F. was an employee of a contract research organization offering vector integration services.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zabaleta, N., Gil-Farina, I. Tracing the fate of AAV vectors in the body. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-02047-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-023-02047-5

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing